U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by Howe & Rusling Inc.

Howe & Rusling Inc. lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 13.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,634 shares of the company’s stock after acquiring an additional 434 shares during the quarter. Howe & Rusling Inc.’s holdings in U.S. Physical Therapy were worth $338,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in USPH. Quantbot Technologies LP purchased a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $82,000. Park Avenue Securities LLC purchased a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $232,000. International Assets Investment Management LLC lifted its holdings in shares of U.S. Physical Therapy by 9,269.0% in the fourth quarter. International Assets Investment Management LLC now owns 2,717 shares of the company’s stock valued at $253,000 after purchasing an additional 2,688 shares in the last quarter. HighTower Advisors LLC lifted its holdings in shares of U.S. Physical Therapy by 47.2% in the third quarter. HighTower Advisors LLC now owns 2,773 shares of the company’s stock valued at $257,000 after purchasing an additional 889 shares in the last quarter. Finally, Channing Capital Management LLC purchased a new stake in shares of U.S. Physical Therapy in the third quarter valued at about $286,000.

Analyst Upgrades and Downgrades

USPH has been the topic of several recent analyst reports. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Barrington Research upped their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, JPMorgan Chase & Co. upped their price target on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $125.67.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 1,500 shares of the stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.96, for a total transaction of $157,440.00. Following the transaction, the insider now directly owns 19,314 shares in the company, valued at approximately $2,027,197.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares in the company, valued at approximately $2,272,834.08. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Eric Joseph Williams sold 1,500 shares of U.S. Physical Therapy stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.96, for a total transaction of $157,440.00. Following the completion of the sale, the insider now owns 19,314 shares in the company, valued at $2,027,197.44. The disclosure for this sale can be found here. Insiders have sold 10,829 shares of company stock worth $1,141,535 in the last ninety days. 1.80% of the stock is owned by insiders.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock opened at $101.46 on Thursday. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $124.11. The firm has a fifty day moving average of $105.01 and a 200-day moving average of $95.78. The firm has a market capitalization of $1.53 billion, a P/E ratio of 75.16, a PEG ratio of 4.82 and a beta of 1.39. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.02. The company had revenue of $154.80 million during the quarter, compared to analyst estimates of $150.24 million. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.58 earnings per share. As a group, analysts predict that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 1.73%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend was Monday, March 11th. U.S. Physical Therapy’s dividend payout ratio is 130.37%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.